Europe Fidaxomicin Market Report 2016
- QYR905910
- 95 Pages
- February 2017
- Pharmaceuticals
This report studies sales (consumption) of Fidaxomicin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these regions, covering
Astellas
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Fidaxomicin in these regions, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Benelux
Spain
Split by applications, this report focuses on sales, market share and growth rate of Fidaxomicin in each application, can be divided into
Hospital
Retail Pharmacies
1 Fidaxomicin Overview 1
1.1 Product Overview and Scope of Fidaxomicin 1
1.2 Specifications of Fidaxomicin 2
1.3 Applications of Fidaxomicin 3
1.4 Fidaxomicin Market by Countries 5
1.4.1 Germany Status and Prospect (2011-2021) 5
1.4.2 France Status and Prospect (2011-2021) 6
1.4.3 UK Status and Prospect (2011-2021) 7
1.4.4 Russia Status and Prospect (2011-2021) 7
1.4.5 Italy Status and Prospect (2011-2021) 8
1.4.6 Benelux Status and Prospect (2011-2021) 9
1.4.7 Spain Status and Prospect (2011-2021) 9
1.5 Europe Market Size (Value and Volume) of Fidaxomicin (2011-2021) 10
1.5.1 Europe Fidaxomicin Sales and Growth Rate (2011-2021) 10
1.5.2 Europe Fidaxomicin Revenue and Growth Rate (2011-2021) 11
2 Europe Fidaxomicin by Manufacturers, Type and Application 12
2.1 Europe Fidaxomicin Market Competition by Manufacturers 12
2.1.1 Europe Fidaxomicin Sales and Market Share of Key Manufacturers (2015 and 2016) 12
2.1.2 Europe Fidaxomicin Revenue and Share by Manufacturers (2015 and 2016) 13
2.2 Europe Fidaxomicin (Volume and Value) by Countries 14
2.2.1 Europe Fidaxomicin Sales and Market Share by Countries (2012-2016) 14
2.2.2 Europe Fidaxomicin Revenue and Market Share by Countries (2012-2016) 16
2.3 Europe Fidaxomicin (Volume) by Application 17
3 Germany Fidaxomicin (Volume, Value and Sales Price) 20
3.1 Germany Fidaxomicin Sales and Value (2012-2016) 20
3.1.1 Germany Fidaxomicin Sales and Growth Rate (2012-2016) 20
3.1.2 Germany Fidaxomicin Revenue and Growth Rate (2012-2016) 21
3.1.3 Germany Fidaxomicin Sales Price Trend (2012-2016) 21
3.2 Germany Fidaxomicin Sales and Market Share by Manufacturers 22
3.3 Germany Fidaxomicin Sales and Market Share by Applications 22
4 UK Fidaxomicin (Volume, Value and Sales Price) 24
4.1 UK Fidaxomicin Sales and Value (2012-2016) 24
4.1.1 UK Fidaxomicin Sales and Growth Rate (2012-2016) 24
4.1.2 UK Fidaxomicin Revenue and Growth Rate (2012-2016) 25
4.1.3 UK Fidaxomicin Sales Price Trend (2012-2016) 26
4.2 UK Fidaxomicin Sales and Market Share by Manufacturers 26
4.3 UK Fidaxomicin Sales and Market Share by Applications 27
5 France Fidaxomicin (Volume, Value and Sales Price) 28
5.1 France Fidaxomicin Sales and Value (2012-2016) 28
5.1.1 France Fidaxomicin Sales and Growth Rate (2012-2016) 28
5.1.2 France Fidaxomicin Revenue and Growth Rate (2012-2016) 29
5.1.3 France Fidaxomicin Sales Price Trend (2012-2016) 29
5.2 France Fidaxomicin Sales and Market Share by Manufacturers 30
5.3 France Fidaxomicin Sales and Market Share by Applications 30
6 Russia Fidaxomicin (Volume, Value and Sales Price) 32
6.1 Russia Fidaxomicin Sales and Value (2012-2016) 32
6.1.1 Russia Fidaxomicin Sales and Growth Rate (2012-2016) 32
6.1.2 Russia Fidaxomicin Revenue and Growth Rate (2012-2016) 33
6.1.3 Russia Fidaxomicin Sales Price Trend (2012-2016) 33
6.2 Russia Fidaxomicin Sales and Market Share by Manufacturers 34
6.3 Russia Fidaxomicin Sales and Market Share by Applications 34
7 Benelux Fidaxomicin (Volume, Value and Sales Price) 36
7.1 Benelux Fidaxomicin Sales and Value (2012-2016) 36
7.1.1 Benelux Fidaxomicin Sales and Growth Rate (2012-2016) 36
7.1.2 Benelux Fidaxomicin Revenue and Growth Rate (2012-2016) 37
7.1.3 Benelux Fidaxomicin Sales Price Trend (2012-2016) 37
7.2 Benelux Fidaxomicin Sales and Market Share by Manufacturers 38
7.3 Benelux Fidaxomicin Sales and Market Share by Applications 38
8 Italy Fidaxomicin (Volume, Value and Sales Price) 40
8.1 Italy Fidaxomicin Sales and Value (2012-2016) 40
8.1.1 Italy Fidaxomicin Sales and Growth Rate (2012-2016) 40
8.1.2 Italy Fidaxomicin Revenue and Growth Rate (2012-2016) 41
8.1.3 Italy Fidaxomicin Sales Price Trend (2012-2016) 41
8.2 Italy Fidaxomicin Sales and Market Share by Manufacturers 42
8.3 Italy Fidaxomicin Sales and Market Share by Applications 42
9 Spain Fidaxomicin (Volume, Value and Sales Price) 44
9.1 Spain Fidaxomicin Sales and Value (2012-2016) 44
9.1.1 Spain Fidaxomicin Sales and Growth Rate (2012-2016) 44
9.1.2 Spain Fidaxomicin Revenue and Growth Rate (2012-2016) 45
9.1.3 Spain Fidaxomicin Sales Price Trend (2012-2016) 45
9.2 Spain Fidaxomicin Sales and Market Share by Manufacturers 46
9.3 Spain Fidaxomicin Sales and Market Share by Applications 46
10 Europe Fidaxomicin Suppliers Analysis 48
10. 1 Company Basic Information 48
10.2 Product Information 49
10.3 Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin 2015-2016 50
11 Fidaxomicin Manufacturing Cost Analysis 51
11.1 Fidaxomicin Key Raw Materials Analysis 51
11.1.1 Key Raw Materials 51
11.1.2 Key Suppliers of Raw Materials 52
11.1.3 Market Concentration Rate of Raw Materials 53
11.2 Proportion of Manufacturing Cost Structure 54
11.2.1 Raw Materials 54
11.2.2 Labor Cost 55
11.2.3 Manufacturing Expenses 55
11.3 Manufacturing Process Analysis of Fidaxomicin 55
12 Industrial Chain, Sourcing Strategy and Downstream Buyers 57
12.1 Fidaxomicin Industrial Chain Analysis 57
12.2 Upstream Raw Materials Sourcing 57
12.3 Downstream Buyers 58
13 Marketing Strategy Analysis, Distributors/Traders 59
13.1 Marketing Channel 59
10.1.1 Direct Marketing 60
10.1.2 Indirect Marketing 60
10.1.3 Marketing Channel Development Trend 60
13.2 Market Positioning 61
13.2.1 Pricing Strategy 61
13.2.2 Brand Strategy 62
13.2.2.1 Introducing pharmaceutical branding strategies 62
13.2.2.2 Building pharmaceutical brands 63
13.2.2.3 Communicating pharmaceutical brands 64
13.2.2.4 Alternative brand models 65
13.2.2.5 The future of pharmaceutical branding 66
13.3 Distributors/Traders List 67
14 Europe Fidaxomicin Market Forecast (2016-2021) 69
14.1 Germany Fidaxomicin Sales Forecast (2016-2021) 69
14.2 UK Fidaxomicin Sales Forecast (2016-2021) 70
14.3 France Fidaxomicin Sales Forecast (2016-2021) 71
14.4 Russia Fidaxomicin Sales Forecast (2016-2021) 73
14.5 Benelux Fidaxomicin Sales Forecast (2016-2021) 74
14.6 Italy Fidaxomicin Sales Forecast (2016-2021) 75
14.7 Spain Fidaxomicin Sales Forecast (2016-2021) 76
14.8 Europe Fidaxomicin Sales Forecast by Application (2016-2021) 77
15 Research Findings and Conclusion 78
16 Appendix 79
Author List 79
Disclosure Section 79
Research Methodology 80
Data Source 82
Disclaimer 82
Figure Picture of Fidaxomicin 1
Table Specifications of Fidaxomicin 2
Table Applications of Fidaxomicin 3
Figure Europe Sales Market Share of Fidaxomicin by Applications in 2015 5
Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 5
Figure France Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 6
Figure UK Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 7
Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 7
Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 8
Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 9
Figure Spain Fidaxomicin Revenue and Growth Rate (2011-2021) 9
Figure Europe Fidaxomicin Sales (K Tablets) and Growth Rate (2011-2021) 10
Figure Europe Fidaxomicin Revenue (M USD) and Growth Rate (2011-2021) 11
Table Europe Fidaxomicin Sales (K Tablets) of Key Manufacturers (2015 and 2016) 12
Table Europe Fidaxomicin Sales Share by Manufacturers (2015 and 2016) 12
Figure 2015 Fidaxomicin Sales Share by Manufacturers 13
Table Europe Fidaxomicin Revenue (M USD) by Manufacturers (2015 and 2016) 13
Table Europe Fidaxomicin Revenue Share by Manufacturers (2015 and 2016) 13
Table 2015 Europe Fidaxomicin Revenue Share by Manufacturers 14
Table Europe Fidaxomicin Sales (K Tablets) and Market Share by Countries (2012-2016) 14
Table Europe Fidaxomicin Sales Share by Countries (2012-2016) 15
Figure Sales Market Share of Fidaxomicin by Countries (2012-2016) 15
Figure Sales Market Share of Fidaxomicin by Countries in 2015 16
Table Europe Fidaxomicin Revenue (M USD) by Countries (2012-2016) 16
Table Europe Fidaxomicin Revenue Share by Countries (2012-2016) 17
Figure Revenue Market Share of Fidaxomicin by Countries (2012-2016) 17
Table Europe Fidaxomicin Sales (K Tablets) by Application (2012-2016) 17
Table Europe Fidaxomicin Sales Share by Application (2012-2016) 18
Figure Sales Market Share of Fidaxomicin by Application (2012-2016) 18
Figure Sales Market Share of Fidaxomicin by Application in 2015 19
Figure Germany Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 20
Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 21
Figure Germany Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 21
Table Germany Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 22
Table Germany Fidaxomicin Market Share by Manufacturers (2015 and 2016) 22
Table Germany Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 22
Table Germany Fidaxomicin Market Share by Applications (2015 and 2016) 23
Figure UK Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 24
Figure UK Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 25
Figure UK Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 26
Table UK Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 26
Table UK Fidaxomicin Market Share by Manufacturers (2015 and 2016) 26
Table UK Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 27
Table UK Fidaxomicin Market Share by Applications (2015 and 2016) 27
Figure France Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 28
Figure France Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 29
Figure France Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 29
Table France Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 30
Table France Fidaxomicin Market Share by Manufacturers (2015 and 2016) 30
Table France Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 30
Table France Fidaxomicin Market Share by Applications (2015 and 2016) 30
Figure Russia Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 32
Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 33
Figure Russia Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 33
Table Russia Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 34
Table Russia Fidaxomicin Market Share by Manufacturers (2015 and 2016) 34
Table Russia Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 34
Table Russia Fidaxomicin Market Share by Applications (2015 and 2016) 34
Figure Benelux Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 36
Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 37
Figure Benelux Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 37
Table Benelux Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 38
Table Benelux Fidaxomicin Market Share by Manufacturers (2015 and 2016) 38
Table Benelux Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 38
Table Benelux Fidaxomicin Market Share by Applications (2015 and 2016) 38
Figure Italy Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 40
Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 41
Figure Italy Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 41
Table Italy Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 42
Table Italy Fidaxomicin Market Share by Manufacturers (2015 and 2016) 42
Table Italy Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 42
Table Italy Fidaxomicin Market Share by Applications (2015 and 2016) 42
Figure Spain Fidaxomicin Sales (K Tablets) and Growth Rate (2012-2016) 44
Figure Spain Fidaxomicin Revenue (M USD) and Growth Rate (2012-2016) 45
Figure Spain Fidaxomicin Sales Price (USD/ Tablets) Trend (2012-2016) 45
Table Spain Fidaxomicin Sales (K Tablets) by Manufacturers (2015 and 2016) 46
Table Spain Fidaxomicin Market Share by Manufacturers (2015 and 2016) 46
Table Spain Fidaxomicin Sales (K Tablets) by Applications (2015 and 2016) 46
Table Spain Fidaxomicin Market Share by Applications (2015 and 2016) 46
Table Astellas Basic Information List 48
Figure Picture of Fidaxomicin 49
Table Astellas Fidaxomicin Product Information 49
Table Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin 2015-2016 50
Table Key Raw Materials of Fidaxomicin 51
Table Suppliers of Raw Materials 52
Figure Manufacturing Cost Structure of Fidaxomicin 54
Figure Manufacturing Process Analysis of Fidaxomicin 55
Figure Fidaxomicin Industrial Chain Analysis 57
Table Major Buyers of Fidaxomicin 58
Figure Marketing Channel for Fidaxomicin 59
Table Distributors/Traders List 67
Figure Germany Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 69
Figure Germany Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 70
Figure UK Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 70
Figure UK Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 71
Figure France Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 71
Figure France Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 72
Figure Russia Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 73
Figure Russia Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 73
Figure Benelux Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 74
Figure Benelux Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 74
Figure Italy Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 75
Figure Italy Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 76
Figure Spain Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2016-2021) 76
Figure Spain Fidaxomicin Revenue (M USD) and Growth Rate Forecast (2016-2021) 77
Table Europe Fidaxomicin Sales (K Tablets) Forecast by Application (2016-2021) 77
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
